ShareProphets : tidm

PZC

PZ Cussons (#PZC) – Nigeria trading conditions “have tightened further”, expected PBT towards bottom end of range

2018-06-13 23:10:36

PZ Cussons - slap on the St Tropez tan and have a go?

Another 'earnings Thursday'. I could write about Cineworld (CINE) again after my post deal announcement review but it really is all about the big US acquisition and I think it overpaid. Instead I turn to the consumer name PZ Cussons (PZC), which has had a slightly unpleasant share price fall today after updating the market with the observation that:

By Chris Bailey | Published 2018-03-15 03:50:43 |

PZ Cussons (#PZC) – profit warning, “subdued levels of consumer confidence and higher levels of competitive intensity”

2018-03-15 00:51:33

PZ Cussons (#PZC) – H1 op profit “approximately 10% lower”, expects FY “broadly in line with the prior year”

2017-12-14 00:14:25

PZ Cussons (#PZC) – “tough trading conditions” in most markets, though reckons it “remains on track”

2017-09-26 23:12:58

PZ Cussons (#PZC) – performance “in line”, “well placed to pursue new opportunities”

2017-06-14 23:12:30

PZ Cussons (#PZC) – trading “in line”, “well placed to pursue new opportunities”

2017-04-12 23:25:59

PZ Cussons (#PZC) – AGM update, “well placed to manage the challenging trading conditions that exist in most markets”

2016-09-27 23:17:57

Boring investing produces generations of riches – the case of PZ Cussons

Yesterday saw the publication of annual results from one of the low-profile but high-quality companies on the market: PZ Cussons (PZC). Underlying results were unexciting but investors were treated to their 43^rd consecutive year-on-year dividend increase from this 19^th century business. It just goes to show that successful investing can be very, very boring.

By Graham Neary | Published 2016-07-27 06:00:14 |

PZ Cussons (#PZC) – FY adj. EPS -0.4% in constant currency, since year end “in line”

2016-07-25 23:11:10

previous 20 Page 4 of 4 (70 articles) next 0

Latest News

Show All

UPDATED: Lucian Miers & Jim Mellon are coming back to Sharestock in 2027: early bird tickets now on sale, event 15% sold out!

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

Evil Banksta weighs in on TekCapital after today’s spooftastic RNS

Good news travels fast but bad news….the case of Skinbiotherapeutics

Mothercare: the end is nigh, don’t blame Trump, I told y’all eons ago

EXPOSE: Nuburu shares in a slump post relisting on American Stock Exchange and latest accounts contain a material error

Letter to Pointon Young, former auditors to Amazing AI

Reinvesting my Satsuma Winnings

Tribal Group – “Proposed Acquisition by Main Capital Partners” provides us with another share tip winner

Quantum Data Energy - why are its shares still suspended?

Recent Comments

TOYIN18 Sep 2026

Thanks Tom, just picked some more up sub 8p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

JOHN BROWN18 Sep 2026

It's outrageous that the likes of Amy Hunt claim that women with Sydney Sweeney's body shape cannot play sport. Who said that sportswomen can't look like Ms Sweeney?

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

MICKTHELINGE18 Sep 2026

If it gets to 3p then construction will be going well and it will be well on the way to 6p+ so interested in why you would sell out then?

Reinvesting my Satsuma Winnings

TOM18 Sep 2026

Whatever Opti's intentions it will have to sell.You could say you should sell now as maybe your last chance to sell at above 8oops too late, now 7.5p to sell

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

I thought that a seasoned reader of financial statements would have clocked that OPTI's HY results to 30/6/26 classed their SBTX shares as non-current assets – meaning that management has no intention to sell them within 12 months.Maybe you assumed that they were forced to class them as non-current because SBTX shares were suspended…but no, the SBTX suspension was lifted weeks before OPTI's sign-off date.And if you believe that OPTI haven't sold all or most of their remaining SBTX shares since June 30th, I'm afraid they saw you coming.There is of course a risk that OPTI has double accounted for its SBTX shares, having included them in both non-current assets and in "cash and equivalents", which might be a fruitful line of enquiry for you.As for Skin's RNS arriving a day outside the standard 10th-20th definition of mid-month, they have had a lot of balls to juggle so a 24hr delay ought to be a cause for congratulations.Why not grab some SBTX shares this afternoon? Could be your last chance to buy back below 12p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

Notwithstanding your ad nauseam negativity on SBTX, I choose to believe the positive indications from the 8 June RNS, including "Growth continued across the company", under Current Trading and Outlook (from a chairman who never speaks with forked tongue). Accordingly, I have helped myself to a nice top-up in anticipation of a welcome trading update on Monday.

Tom Winnifrith Bearcast: Hang on for the PS in the podcast

BOBINS18 Sep 2026

lets hope the Houthis keep away from the Saudi Mines?

Reinvesting my Satsuma Winnings

Charles18 Sep 2026

Easy work for the FCA with you having laid it out.

EXPOSE: Paul Mathieson and the strike off: you might think that, I could not comment

TOM18 Sep 2026

darren has done something , really working now

Tom Winnifrith Bearcast: Hang on for the PS in the podcast